Cargando…

Deficits in striatal dopamine release in cannabis dependence

Most drugs of abuse lead to a general blunting of dopamine release in the chronic phase of dependence, which contributes to poor outcome. To test whether cannabis dependence is associated with a similar dopaminergic deficit, we examined striatal and extrastriatal dopamine release in severely cannabi...

Descripción completa

Detalles Bibliográficos
Autores principales:	van de Giessen, Elsmarieke, Weinstein, Jodi J., Cassidy, Clifford M., Haney, Margaret, Dong, Zhengchao, Ghazzaoui, Rassil, Ojeil, Najate, Kegeles, Lawrence S., Xu, Xiaoyan, Vadhan, Nehal P., Volkow, Nora D., Slifstein, Mark, Abi-Dargham, Anissa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033654/ https://www.ncbi.nlm.nih.gov/pubmed/27001613 http://dx.doi.org/10.1038/mp.2016.21

Ejemplares similares

PET imaging of dopamine-D2 receptor internalization in schizophrenia
por: Weinstein, Jodi J., et al.
Publicado: (2017)

Mechanisms of Working Memory Impairment in Schizophrenia
por: Van Snellenberg, Jared X., et al.
Publicado: (2016)

Striatal Dopamine Release in Schizophrenia Comorbid with Substance Dependence
por: Thompson, Judy L., et al.
Publicado: (2012)

43.4 THE ROLE OF MOLECULAR IMAGING IN GUIDING DRUG DEVELOPMENT
por: Abi-Dargham, Anissa, et al.
Publicado: (2018)

3.3 DISTURBANCES IN NEURAL OSCILLATIONS, GLUTAMATE, AND GABA: EFFECTS OF KETAMINE AND COMPARISON TO SCHIZOPHRENIA
por: Kegeles, Lawrence, et al.
Publicado: (2018)

27. THE ROLE OF DOPAMINE IN SHAPING CIRCUITRY RELATED TO SCHIZOPHRENIA AND ADDICTION
por: Abi-Dargham, Anissa
Publicado: (2018)

Deep rTMS of the insula and prefrontal cortex in smokers with schizophrenia: Proof-of-concept study
por: Moeller, Scott J., et al.
Publicado: (2022)

Dopamine in the history of the schizophrenic brain: recent contributions of brain-imaging studies
por: Lamelle, Marc, et al.
Publicado: (2000)

Dopamine D(1) receptors in cocaine dependence measured with PET and the choice to self-administer cocaine
por: Martinez, Diana, et al.
Publicado: (2009)

Lower striatal dopamine D(2/3 )receptor availability in obese compared with non-obese subjects
por: de Weijer, Barbara A, et al.
Publicado: (2011)

Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
por: McCutcheon, Robert A., et al.
Publicado: (2019)

Relevance of the Kappa Dynorphin System to Schizophrenia and Its Therapeutics
por: Abi-Dargham, Anissa
Publicado: (2021)

Smoked Cannabis Effects in Cannabis Users at Clinical High-Risk for Psychosis: A Further Investigation of Cognition and Reward
por: Madden, Sean P., et al.
Publicado: (2022)

Striatal dopamine receptor binding in morbidly obese women before and after gastric bypass surgery and its relationship with insulin sensitivity
por: de Weijer, Barbara A., et al.
Publicado: (2014)

GABA level, gamma oscillation, and working memory performance in schizophrenia
por: Chen, Chi-Ming A., et al.
Publicado: (2014)

27.1 TRANSLATIONAL EVIDENCE OF DOPAMINE-RELATED ALTERATIONS OF BASAL GANGLIA AND THALAMO-CORTICAL NEUROCIRCUITRY IN SCHIZOPHRENIA: A FULL CLINIC-TO-BENCH-TO-CLINIC BACK-TRANSLATION
por: Van Snellenberg, Jared, et al.
Publicado: (2018)

Early Versus Late Onset of Cannabis Use: Differences in Striatal Response to Cannabis Cues
por: Wetherill, Reagan R., et al.
Publicado: (2016)

Medial Prefrontal Cortex Dysfunction Mediates Working Memory Deficits in Patients With Schizophrenia
por: Williams, John C., et al.
Publicado: (2022)

Brain opioid segments and striatal patterns of dopamine release induced by naloxone and morphine
por: Shokri‐Kojori, Ehsan, et al.
Publicado: (2021)

Preferential binding to dopamine D(3) over D(2) receptors by cariprazine in patients with schizophrenia using PET with the D(3)/D(2) receptor ligand [(11)C]-(+)-PHNO
por: Girgis, Ragy R., et al.
Publicado: (2016)

Decreased Spontaneous Eye Blink Rates in Chronic Cannabis Users: Evidence for Striatal Cannabinoid-Dopamine Interactions
por: Kowal, Mikael A., et al.
Publicado: (2011)

The SPECT tracer [(123)I]ADAM binds selectively to serotonin transporters: a double-blind, placebo-controlled study in healthy young men
por: van de Giessen, Elsmarieke, et al.
Publicado: (2010)

Reproducibility assessment of neuromelanin-sensitive magnetic resonance imaging protocols for region-of-interest and voxelwise analyses
por: Wengler, Kenneth, et al.
Publicado: (2019)

An evaluation of the brain distribution of [(11)C]GSK1034702, a muscarinic-1 (M(1)) positive allosteric modulator in the living human brain using positron emission tomography
por: Ridler, Khanum, et al.
Publicado: (2014)

Variable activation in striatal subregions across components of a social influence task in young adult cannabis users
por: Gilman, Jodi M., et al.
Publicado: (2016)

Association between striatal dopamine D(2)/D(3) receptors and brain activation during visual attention: effects of sleep deprivation
por: Tomasi, D, et al.
Publicado: (2016)

Interaction of Cannabis Use Disorder and Striatal Connectivity in Antipsychotic Treatment Response
por: Blair Thies, Melanie, et al.
Publicado: (2020)

Reliability and Reproducibility of Neuromelanin‐Sensitive Imaging of the Substantia Nigra: A Comparison of Three Different Sequences
por: van der Pluijm, Marieke, et al.
Publicado: (2020)

Caffeine increases striatal dopamine D(2)/D(3) receptor availability in the human brain
por: Volkow, N D, et al.
Publicado: (2015)

A brain imaging study of dopamine receptor D(2) availability in cannabis dependent users after recovery from cannabis-induced psychosis
por: Weinstein, Aviv M.
Publicado: (2023)

Cortical Control of Striatal Dopamine Transmission via Striatal Cholinergic Interneurons
por: Kosillo, Polina, et al.
Publicado: (2016)

Age-related differences in striatal dopamine D1 receptors mediate subjective drug effects
por: Manza, Peter, et al.
Publicado: (2023)

Association of genetic ancestry with striatal dopamine D2/D3 receptor availability
por: Wiers, Corinde E., et al.
Publicado: (2017)

Local control of striatal dopamine release
por: Cachope, Roger, et al.
Publicado: (2014)

Abnormal Striatal Dopamine Transmission in Schizophrenia
por: Brunelin, Jerome, et al.
Publicado: (2013)

Striatal Dopamine Signals and Reward Learning
por: Bech, Pol, et al.
Publicado: (2023)

Opioid antagonists are associated with a reduction in the symptoms of schizophrenia: a meta-analysis of controlled trials
por: Clark, Samuel D., et al.
Publicado: (2020)

Importance of a standard unit dose for cannabis research
por: Volkow, Nora D., et al.
Publicado: (2020)

Coordinating cannabis data collection globally: Policy implications
por: Weiss, Susan R. B., et al.
Publicado: (2021)

Editorial: Psychological Aspects of Cannabis Use and Cannabis Use Disorder
por: Feingold, Daniel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nl97p5m9ui5nj3fed4lmu42ns5